Printed from Voxsanity (voxsanity.com.au) — NCT06358391 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Atrial Fibrillation
Atrial Fibrillation Trial, Recruiting
NCT06358391
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have a confirmed diagnosis (shown in their medical records) of one of the following heart conditions:
- Atrial fibrillation (any type — paroxysmal, persistent, long-standing persistent, or permanent), confirmed by an ECG recording lasting at least 30 seconds, with symptoms such as tiredness, heart palpitations, breathlessness, chest discomfort, sleep problems, or stress
- Paroxysmal Supraventricular Tachycardia — a condition where the heart suddenly beats very fast (150–200 beats per minute) and then stops abruptly
- Ectopic Atrial Rhythm Tachycardia — a fast heart rhythm (under 250 beats per minute) originating from an unusual spot in the heart, with a specific pattern visible on an ECG
- Ventricular Tachycardia — a fast heart rhythm of 100 or more beats per minute originating in the lower chambers of the heart
- An arrhythmia requiring a specific heart procedure (involving access to the left side of the heart, including a procedure to close off a small pouch in the heart called the left atrial appendage), in people with a moderate or higher stroke risk, bleeding risk, or who cannot take blood thinners
- Mitral stenosis (a narrowing of a heart valve) requiring a specific non-surgical procedure to open the valve, confirmed by an ultrasound of the heart, with symptoms such as breathlessness, difficulty lying flat to sleep, coughing, or chest pain
- People who have read and understood the study information and have voluntarily signed a consent form agreeing to take part
Who may not be able to join:
- People with significant heart defects present from birth, such as a hole between the upper chambers of the heart or abnormalities of the pulmonary veins (a small natural opening called a patent foramen ovale does not disqualify someone)
- People who have a blood clot in the left side of the heart
- People whose atrial fibrillation is caused by a treatable underlying condition, such as an overactive thyroid or recent chest surgery
- People with a known or suspected non-cancerous tumour in the left side of the heart (called a myxoma)
- People with unstable angina (severe chest pain that is not controlled)
- People who already have paralysis of one side of the diaphragm (the main breathing muscle)
- People who cannot take blood thinners or contrast dye used in imaging procedures
- People with liver disease (including active hepatitis) or kidney disease
- People who have had a stroke or mini-stroke (TIA) in the six months before signing the consent form
- People with a malignant cancer, a blood disorder, or a life expectancy of less than one year
- People who are currently enrolled in, or plan to join, another clinical trial of a drug, device, or biological treatment that could affect this study's results
- People who are unwilling or unable to follow all study procedures and required follow-up visits
- People who are pregnant, planning to become pregnant, or currently breastfeeding
- People considered ineligible by the trial investigator for any other reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Principal Investigator: Sang-Weon Park, MD, Ph.D, Sejong General Hospital
Phone: +82-31-816-3546
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Starmed
Registry
ClinicalTrials.gov
Start date
21 August 2024
Est. completion
21 August 2025
Where this trial is recruiting
🇰🇷 South Korea
Primary endpoints
First-pass TSP Success Rate (percent)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.